Denali Therapeutics Inc Revenue per Employee (DNLI), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Denali Therapeutics Inc   (NASDAQ: DNLI)
 

Denali Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Denali Therapeutics Inc 's Revenue per employee grew on a trailing twelve month basis to $ 7,165, above the company average.
Within the Healthcare sector Denali Therapeutics Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Denali Therapeutics Inc has 503 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DNLI Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change - - - - -
Sales per Employee (TTM) $ 7,165 - - - -
DNLI's Total Ranking # # # # #
Seq. Revenue Change - - - - -

DNLI Company Profile >> Back to DNLI Efficiency Comparisons >> Compare DNLI Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 709,881 $ 310,863 $ 1,274
(Jun 30 2021)   (Mar 31 2018)



Financial Statements
Denali Therapeutics Inc 's Revenue MRQ $ 4 Millions Visit DNLI's Income Statement
Denali Therapeutics Inc 's Revenues TTM $ 4 Millions Visit DNLI's aggregate revenue growth
What are DNLI's Sales? Visit DNLI's Sales by Segment




Other Ratios
Denali Therapeutics Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
DNLI's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for DNLI's Competitors
Revenue per Employee for DNLI's Suppliers
Revenue per Employee for DNLI's Customers

You may also want to know
DNLI's Sales Growth Rates DNLI's Pe Price to earnings ratio DNLI's Receivables Turnover Ratio DNLI's Stock Quote
DNLI's Net Income Growth Rates DNLI's Ps Price to Sales ratio DNLI's Sales per Employee DNLI's Asset Turnover Ratio
DNLI's Net Margin DNLI's Pb Price to Book ratio DNLI's Financial Strength Ratios DNLI's Dividend Payout Ratio
Date modified: 2026-09-06T12:18:36+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Absci Corp  11,150.00 $ 1.561  Million 140 
Pluri Inc   11,043.48 $ 1.016  Million 92 
Pulse Biosciences Inc   10,215.52 $ 1.185  Million 116 
Roivant Sciences Ltd   10,042.67 $ 7.532  Million 750 
Skinvisible Inc   10,000.00 $ 0.020  Million 2 
Aclarion Inc   7,615.27 $ 0.084  Million 11 
Lightwave Logic Inc   7,360.32 $ 0.250  Million 34 
Co diagnostics Inc   6,272.93 $ 0.721  Million 115 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.